G71.09
Other specified muscular dystrophies
Clinical Classification Guidelines
Inclusion Terms
- Benign scapuloperoneal muscular dystrophy with early contractures [Emery-Dreifuss]
- Congenital muscular dystrophy NOS
- Congenital muscular dystrophy with specific morphological abnormalities of the muscle fiber
- Distal muscular dystrophy
- Ocular muscular dystrophy
- Oculopharyngeal muscular dystrophy
- Scapuloperoneal muscular dystrophy
Medical Intelligence & Overview
Other specified muscular dystrophies (ICD-10 code G71.09) refer to a group of genetic muscle disorders characterized by progressive weakness and degeneration of skeletal muscles. These conditions vary in severity, onset, and affected muscle groups, and may include a range of specific types such as scapuloperoneal, ocular, congenital, and distal muscular dystrophies. While some forms are benign, others can significantly impair mobility and quality of life.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents De novo gene mutations occurring spontaneously Mutations affecting muscle fiber structure and function Specific morphological abnormalities in muscle tissue Family history of muscular dystrophy in some cases
Key Symptoms: Progressive muscle weakness and wasting Muscle stiffness or contractures, especially in early stages Difficulty with movements such as lifting, walking, or reaching Muscle cramps and fatigue during activity Potential respiratory or cardiac complications if muscles involved are vital Ocular symptoms like drooping eyelids or difficulty swallowing in some types Distal muscle weakness affecting hands and feet Scapular winging or shoulder weakness in scapuloperoneal forms Early-onset muscle weakness in congenital types
Diagnostic & Treatment
Diagnosis Path: Detailed medical and family history assessment Physical examination focusing on muscle strength and abnormalities Electromyography (EMG) to assess muscle electrical activity Muscle biopsy revealing specific morphological muscle fiber changes Genetic testing to identify mutations associated with various muscular dystrophies Molecular studies to define the specific type and prognosis
Treatment Protocols: Physical therapy to maintain muscle strength and flexibility Occupational therapy for assistance with daily activities Use of assistive devices such as braces, wheelchairs, or orthoses Medications to manage symptoms like muscle cramps or contractures Monitoring and treating cardiac or respiratory issues if they develop Genetic counseling for affected families Participation in clinical trials as new therapies are explored
Clinical Advice & FAQs
Billing Guidance
Is G71.09 a billable ICD-10 code?
Yes, G71.09 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.09?
Clinical documentation must specify the nature of Other specified muscular dystrophies and any associated comorbidities for accurate reporting.
Cite this Clinical Reference